Amgen, Inc.

Amgen is a global leader in biotechnology, specializing in the development of biologic medicines derived from living cells. The company is committed to advancing science and innovation to improve patient care and health outcomes. Amgen's operations encompass a wide range of activities, including research and development, clinical trials, and the production of biosimilars. The organization emphasizes its dedication to corporate governance, business ethics, and compliance, ensuring that its practices align with high standards of integrity and responsibility. Amgen also focuses on environmental, social, and governance (ESG) initiatives, aiming to promote health equity, diversity, and sustainability within the communities it serves. The company actively engages in educational outreach and supports various scientific community initiatives, reflecting its commitment to fostering a culture of inclusivity and collaboration in the field of biotechnology.

Driving directions from: